Battle of Thermopylae: 300 Spartans (natural killer cells plus obinutuzumab) versus the immortal warriors (chronic lymphocytic leukemia cells) of Xerxes’ army

AIM: To analyze the effects of subcutaneous or intravenous rituximab + lymphokine-activated killer cells, obinutuzumab or ibrutinib on natural killer (NK) cell levels in chronic lymphocytic leukemia and follicular lymphoma patients. PATIENTS & METHODS: The distribution of peripheral blood NK cel...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Muñoz, Ricardo, Nájera, María-Josefa, Feliu, Jesús, Antón-Remírez, Judith, Ramalle-Gómara, Enrique, Marín-Gorricho, Raquel, Peralta, Raisa, Gutiérrez-Gamarra, Elena, Nuñez-Rodriguez, Jessica, Zafra-Morales, Ricardo, Aguinaga, Lorea, Nebot-Villacampa, María-Jose, Hernandez-Pérez, Prisma-Monserrat, Farfán-Quiroga, Giovanna, Panizo, Carlos, Domínguez-Garrido, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900973/
https://www.ncbi.nlm.nih.gov/pubmed/31827894
http://dx.doi.org/10.2144/fsoa-2019-0064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900973/
https://www.ncbi.nlm.nih.gov/pubmed/31827894
http://dx.doi.org/10.2144/fsoa-2019-0064

Ejemplares similares